Table 2.
Determination of the match or mismatch between HLA class I epitopes in B-CLL patients and in NK cells used in the cytotoxicity assays shown in Fig. 2A.
| Combination | Match | Resistance |
|---|---|---|
| NK1 or NK2/CLL1 | N.D | No |
| NK1 or NK2/CLL2 | N.D | No |
| NK1 or NK2/CLL4 | N.D | No |
| NK1 or NK2/CLL7 | N.D | No |
| NK1 or NK2/CLL8 | N.D | No |
| NK1 or NK2/CLL9 | N.D | No |
| NK1 or NK2/CLL10 | N.D | No |
| NK3 or NK4/CLL1 | No | No |
| NK3 or NK4/CLL3 | YES | No |
| NK3 or NK4/CLL5 | YES | No |
| NK3 or NK4/CLL11 | No | No |
| NK3 or NK4/CLL12 | No | No |
| NK3 or NK4/CLL13 | No | No |
| NK5 or NK6/CLL14 | No | No |
| NK5 or NK6/CLL15 | No | No |
| NK5 or NK6/CLL16 | No | No |
| NK5 or NK6/CLL17 | No | No |
| NK7/CLL6 | No | No |
| NK9 or NK10/CLL19 | No | No |
| NK9 or NK10/CLL20 | No | No |
| NK9 or NK10/CLL21 | No | No |
| NK9 or NK10/2nd CLL5 | YES | YES |
| NK9 or NK10/2nd CLL8 | No | YES |
| NK9 or NK10/CLL18 | No | YES |
Bold indicates the situations in which a match or a resistance could be detected.
N.D. not determined.